NHS Expands Access to Life-Changing Drug for MS Patients

The UK National Health Service (NHS) in England is now providing fampridine, a drug that can significantly improve mobility for thousands of multiple sclerosis (MS) patients. The move aims to enhance the quality of life for those affected by the condition.